MX338594B - Un procedimiento para el procesamiento de partículas de principios farmaceuticos activos. - Google Patents
Un procedimiento para el procesamiento de partículas de principios farmaceuticos activos.Info
- Publication number
- MX338594B MX338594B MX2012012215A MX2012012215A MX338594B MX 338594 B MX338594 B MX 338594B MX 2012012215 A MX2012012215 A MX 2012012215A MX 2012012215 A MX2012012215 A MX 2012012215A MX 338594 B MX338594 B MX 338594B
- Authority
- MX
- Mexico
- Prior art keywords
- active pharmaceutical
- pharmaceutical ingredients
- particle processing
- pharmaceutical ingredient
- processing
- Prior art date
Links
- 239000008186 active pharmaceutical agent Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 239000002245 particle Substances 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/02—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT105058A PT105058B (pt) | 2010-04-21 | 2010-04-21 | Processo para processamento de partículas de ingredientes activos farmacêuticos |
| PCT/GB2011/000631 WO2011131947A2 (en) | 2010-04-21 | 2011-04-21 | A process for particle processing of active pharmaceutical ingredients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2012012215A MX2012012215A (es) | 2013-05-09 |
| MX338594B true MX338594B (es) | 2016-04-25 |
Family
ID=44194836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012012215A MX338594B (es) | 2010-04-21 | 2011-04-21 | Un procedimiento para el procesamiento de partículas de principios farmaceuticos activos. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9956144B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2560620B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6347608B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102970978B (cg-RX-API-DMAC7.html) |
| BR (1) | BR112012026941A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2796978C (cg-RX-API-DMAC7.html) |
| IL (1) | IL222596B (cg-RX-API-DMAC7.html) |
| MX (1) | MX338594B (cg-RX-API-DMAC7.html) |
| PL (1) | PL2560620T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT105058B (cg-RX-API-DMAC7.html) |
| RU (1) | RU2597790C2 (cg-RX-API-DMAC7.html) |
| SG (1) | SG185003A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011131947A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8691145B2 (en) | 2009-11-16 | 2014-04-08 | Flodesign Sonics, Inc. | Ultrasound and acoustophoresis for water purification |
| US10993879B2 (en) | 2010-02-08 | 2021-05-04 | Shenzhen Evergreen Therapeutics Co., Ltd. | Pulmonary delivery of progestogen |
| US10987361B2 (en) | 2010-02-08 | 2021-04-27 | Shenzhen Evergreen Therapeutics Co., Ltd. | Treating auto-immune and auto-inflammatory diseases |
| CN102811730B (zh) | 2010-02-08 | 2014-07-09 | 杜涛 | 孕激素作为糖皮质激素增敏剂的使用 |
| US9421553B2 (en) | 2010-08-23 | 2016-08-23 | Flodesign Sonics, Inc. | High-volume fast separation of multi-phase components in fluid suspensions |
| US10322949B2 (en) | 2012-03-15 | 2019-06-18 | Flodesign Sonics, Inc. | Transducer and reflector configurations for an acoustophoretic device |
| US9796956B2 (en) | 2013-11-06 | 2017-10-24 | Flodesign Sonics, Inc. | Multi-stage acoustophoresis device |
| US9688958B2 (en) | 2012-03-15 | 2017-06-27 | Flodesign Sonics, Inc. | Acoustic bioreactor processes |
| US9752113B2 (en) | 2012-03-15 | 2017-09-05 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| US9458450B2 (en) | 2012-03-15 | 2016-10-04 | Flodesign Sonics, Inc. | Acoustophoretic separation technology using multi-dimensional standing waves |
| US9752114B2 (en) | 2012-03-15 | 2017-09-05 | Flodesign Sonics, Inc | Bioreactor using acoustic standing waves |
| US9567559B2 (en) | 2012-03-15 | 2017-02-14 | Flodesign Sonics, Inc. | Bioreactor using acoustic standing waves |
| US9783775B2 (en) | 2012-03-15 | 2017-10-10 | Flodesign Sonics, Inc. | Bioreactor using acoustic standing waves |
| US10689609B2 (en) | 2012-03-15 | 2020-06-23 | Flodesign Sonics, Inc. | Acoustic bioreactor processes |
| US9745548B2 (en) | 2012-03-15 | 2017-08-29 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| US10370635B2 (en) | 2012-03-15 | 2019-08-06 | Flodesign Sonics, Inc. | Acoustic separation of T cells |
| US9950282B2 (en) | 2012-03-15 | 2018-04-24 | Flodesign Sonics, Inc. | Electronic configuration and control for acoustic standing wave generation |
| US9272234B2 (en) | 2012-03-15 | 2016-03-01 | Flodesign Sonics, Inc. | Separation of multi-component fluid through ultrasonic acoustophoresis |
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| US11179747B2 (en) | 2015-07-09 | 2021-11-23 | Flodesign Sonics, Inc. | Non-planar and non-symmetrical piezoelectric crystals and reflectors |
| US10967298B2 (en) | 2012-03-15 | 2021-04-06 | Flodesign Sonics, Inc. | Driver and control for variable impedence load |
| PT106237B (pt) * | 2012-03-30 | 2015-03-19 | Hovione Farmaci Ncia S A | Produção de partículas substancialmente monodispersas utilizando moagem e separação por membranas |
| US10737953B2 (en) | 2012-04-20 | 2020-08-11 | Flodesign Sonics, Inc. | Acoustophoretic method for use in bioreactors |
| US11324873B2 (en) | 2012-04-20 | 2022-05-10 | Flodesign Sonics, Inc. | Acoustic blood separation processes and devices |
| PT106738B (pt) * | 2013-01-09 | 2015-06-08 | Hovione Farmaciencia Sa | Método para o controlo do fenómeno de degradação difusional de ostwald (ostwald ripening) no processamento de partículas de um ingrediente farmacêutico |
| SG11201508804QA (en) * | 2013-04-25 | 2015-11-27 | Flodesign Sonics Inc | Excipient removal from pharmacological samples |
| US9745569B2 (en) | 2013-09-13 | 2017-08-29 | Flodesign Sonics, Inc. | System for generating high concentration factors for low cell density suspensions |
| CN106061482A (zh) | 2013-10-08 | 2016-10-26 | 拉姆医疗公司 | 用于治疗淋巴管平滑肌瘤病的雷帕霉素 |
| EP3092049A1 (en) | 2014-01-08 | 2016-11-16 | Flodesign Sonics Inc. | Acoustophoresis device with dual acoustophoretic chamber |
| PT107433B (pt) * | 2014-01-28 | 2018-12-04 | Hovione Farm S A | Processo de redução e controlo do tamanho de partícula |
| US10307371B2 (en) | 2014-02-11 | 2019-06-04 | AI Therapeutics, Inc. | Rapamycin for the treatment of lymphangioleiomyomatosis |
| RU2016136348A (ru) | 2014-02-11 | 2018-03-16 | Лэм Терапьютикс, Инк. | Рапамицин для лечения лимфангиолейомиоматоза |
| PT107567B (pt) * | 2014-03-31 | 2019-02-13 | Hovione Farm S A | Secador por atomização com atomizador múltiplo, método para o aumento de escala de pós para inalação secos por dispositivo de atomização múltiplo e uso de vários atomizadores num secador por atomização |
| CN106659686A (zh) | 2014-04-04 | 2017-05-10 | 拉姆医疗公司 | 用于治疗年龄相关病况的可吸入雷帕霉素制剂 |
| US9744483B2 (en) | 2014-07-02 | 2017-08-29 | Flodesign Sonics, Inc. | Large scale acoustic separation device |
| KR20170095807A (ko) * | 2014-10-07 | 2017-08-23 | 램 테라퓨틱스, 인코포레이티드 | 폐 고혈압의 치료를 위한 흡입가능 라파마이신 제제 |
| MA40910A (fr) | 2014-11-07 | 2017-09-12 | Civitas Therapeutics Inc | Poudres de rapamycine pour administration pulmonaire |
| WO2016130645A1 (en) | 2015-02-10 | 2016-08-18 | Lam Therapeutics, Inc. | Rapamycin for the treatment of lymphangioleiomyomatosis |
| US10106770B2 (en) | 2015-03-24 | 2018-10-23 | Flodesign Sonics, Inc. | Methods and apparatus for particle aggregation using acoustic standing waves |
| PT108368B (pt) | 2015-03-31 | 2018-11-05 | Hovione Farm S A | Produção contínua de partículas |
| WO2016176663A1 (en) | 2015-04-29 | 2016-11-03 | Flodesign Sonics, Inc. | Acoustophoretic device for angled wave particle deflection |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| US11021699B2 (en) | 2015-04-29 | 2021-06-01 | FioDesign Sonics, Inc. | Separation using angled acoustic waves |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| BR112017024713B1 (pt) | 2015-05-20 | 2022-09-27 | Flodesign Sonics, Inc | Método para a separação de um segundo fluido ou um particulado de um fluido principal |
| WO2016201385A2 (en) | 2015-06-11 | 2016-12-15 | Flodesign Sonics, Inc. | Acoustic methods for separation cells and pathogens |
| US11034701B2 (en) | 2015-06-16 | 2021-06-15 | Nanophagix LLC | Drug delivery and imaging chemical conjugate, formulations and methods of use thereof |
| US11474085B2 (en) | 2015-07-28 | 2022-10-18 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| US11459540B2 (en) | 2015-07-28 | 2022-10-04 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| PT109030B (pt) | 2015-12-15 | 2019-09-25 | Hovione Farmaciência, S.A. | Preparação de partículas inaláveis de zafirlucaste |
| US10710006B2 (en) | 2016-04-25 | 2020-07-14 | Flodesign Sonics, Inc. | Piezoelectric transducer for generation of an acoustic standing wave |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| CA3023090A1 (en) | 2016-05-03 | 2017-11-09 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
| US11085035B2 (en) | 2016-05-03 | 2021-08-10 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
| CN110494543A (zh) | 2016-10-19 | 2019-11-22 | 弗洛设计声能学公司 | 通过声学的亲和细胞提取 |
| JP2021507561A (ja) | 2017-12-14 | 2021-02-22 | フロデザイン ソニックス， インク．Ｆｌｏｄｅｓｉｇｎ Ｓｏｎｉｃｓ， Ｉｎｃ． | 音響トランスデューサドライバ及びコントローラ |
| WO2022256720A2 (en) | 2021-06-03 | 2022-12-08 | Arcadia Medicine, Inc. | Enantiomeric entactogen compositions and methods of their use |
| EP4551196A1 (en) | 2022-07-04 | 2025-05-14 | Hovione Scientia Limited | Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation |
| WO2025064867A1 (en) * | 2023-09-21 | 2025-03-27 | Yuva Biosciences, Inc. | Delivery system for mitochondrial health enhancers |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0725789B2 (ja) | 1990-09-10 | 1995-03-22 | シェリング・コーポレーション | フランカルボン酸モメタゾン―水和物、その製造法および医薬組成物 |
| US6187765B1 (en) * | 1997-10-09 | 2001-02-13 | Schering Corporation | Mometasone furoate suspensions for nebulization |
| US6184765B1 (en) * | 1999-01-07 | 2001-02-06 | Nec Research Institute, Inc. | Switch useful at superconducting temperatures and comprising superconducting material |
| US6555139B2 (en) * | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
| GB9925934D0 (en) | 1999-11-03 | 1999-12-29 | Glaxo Group Ltd | Novel apparatus and process |
| GB0125604D0 (en) * | 2001-10-25 | 2001-12-19 | Glaxo Group Ltd | Novel process |
| JP4684545B2 (ja) | 2002-09-26 | 2011-05-18 | 大日本住友製薬株式会社 | 溶出性の良好なイソキサゾール誘導体経口製剤 |
| JP4875979B2 (ja) | 2004-03-31 | 2012-02-15 | 富山化学工業株式会社 | 難溶性薬物の微粒子分散液およびその製造方法 |
| EP1595534A1 (en) * | 2004-05-13 | 2005-11-16 | Universiteit Utrecht Holding B.V. | Gel composition comprising charged polymers |
| BRPI0517204A (pt) * | 2004-12-17 | 2008-09-30 | Cipla Ltd | sulfato de levosalbutamol cristalino (forma i), sulfato de levosalbutamol cristalino (forma ii), sulfato de levosalbutamol cristalino (forma iii), processo para preparar a forma i do sulfato de levosalbutamol cristalino, processo para preparar a forma ii do sulfato de levosalbutamol cristalino, processo para preparar a forma iii do sulfato de levosalbutamol, composição farmacêutica, composto, combinação, pó seco para inalador, processo para preparar um pó seco para inalador, processo para preparar uma composição famacêutica, processo para fabricação de uma composição farmacêutica, método para tratamento de um mamìfero, e uso de uma combinação de salbutamol |
| WO2006073154A1 (ja) | 2005-01-07 | 2006-07-13 | Eisai R&D Management Co., Ltd. | 医薬組成物及びその製造方法 |
| US20060193818A1 (en) * | 2005-02-25 | 2006-08-31 | Southall Michael D | Compositions containing amines and use thereof |
| DE102005011786A1 (de) | 2005-03-11 | 2006-09-14 | Pharmasol Gmbh | Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen |
| GB0523576D0 (en) | 2005-11-18 | 2005-12-28 | Theradeas Ltd | Drug composition and its use in therapy |
| US20070178051A1 (en) | 2006-01-27 | 2007-08-02 | Elan Pharma International, Ltd. | Sterilized nanoparticulate glucocorticosteroid formulations |
| JP4879349B2 (ja) | 2007-07-31 | 2012-02-22 | 大塚製薬株式会社 | アリピプラゾール懸濁液及び凍結乾燥製剤の製造方法 |
| EP2050437A1 (en) | 2007-10-15 | 2009-04-22 | Laboratoires SMB | Improved pharmaceutical dry powder compositions for inhalation. |
| EP2156823A1 (en) * | 2008-08-14 | 2010-02-24 | Pharmatex Italia Srl | Process for the preparation of sterile powdered pharmeceutical compounds in the form of micro and nanoparticles |
-
2010
- 2010-04-21 PT PT105058A patent/PT105058B/pt active IP Right Grant
-
2011
- 2011-04-21 SG SG2012078614A patent/SG185003A1/en unknown
- 2011-04-21 CA CA2796978A patent/CA2796978C/en active Active
- 2011-04-21 CN CN201180024407.2A patent/CN102970978B/zh active Active
- 2011-04-21 RU RU2012149459/15A patent/RU2597790C2/ru active
- 2011-04-21 JP JP2013505534A patent/JP6347608B2/ja active Active
- 2011-04-21 PL PL11718765T patent/PL2560620T3/pl unknown
- 2011-04-21 WO PCT/GB2011/000631 patent/WO2011131947A2/en not_active Ceased
- 2011-04-21 MX MX2012012215A patent/MX338594B/es active IP Right Grant
- 2011-04-21 BR BR112012026941A patent/BR112012026941A2/pt not_active Application Discontinuation
- 2011-04-21 US US13/642,397 patent/US9956144B2/en active Active
- 2011-04-21 EP EP11718765.8A patent/EP2560620B1/en active Active
-
2012
- 2012-10-21 IL IL222596A patent/IL222596B/en active IP Right Grant
-
2016
- 2016-09-09 JP JP2016176303A patent/JP6857467B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102970978B (zh) | 2017-05-10 |
| BR112012026941A2 (pt) | 2016-07-12 |
| SG185003A1 (en) | 2012-11-29 |
| EP2560620B1 (en) | 2020-09-16 |
| CN102970978A (zh) | 2013-03-13 |
| WO2011131947A3 (en) | 2012-01-05 |
| JP6857467B2 (ja) | 2021-04-14 |
| JP6347608B2 (ja) | 2018-06-27 |
| JP2017019845A (ja) | 2017-01-26 |
| IL222596B (en) | 2019-03-31 |
| PL2560620T3 (pl) | 2021-04-06 |
| WO2011131947A2 (en) | 2011-10-27 |
| US20130203717A1 (en) | 2013-08-08 |
| PT105058A (pt) | 2011-10-21 |
| EP2560620A2 (en) | 2013-02-27 |
| CA2796978C (en) | 2019-07-02 |
| MX2012012215A (es) | 2013-05-09 |
| RU2597790C2 (ru) | 2016-09-20 |
| JP2013525338A (ja) | 2013-06-20 |
| CA2796978A1 (en) | 2011-10-27 |
| US9956144B2 (en) | 2018-05-01 |
| IL222596A0 (en) | 2012-12-31 |
| PT105058B (pt) | 2013-04-17 |
| RU2012149459A (ru) | 2014-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX338594B (es) | Un procedimiento para el procesamiento de partículas de principios farmaceuticos activos. | |
| WO2013130669A8 (en) | Pharmaceutical composition and administration thereof | |
| WO2012042224A3 (en) | Pharmaceutical composition comprising deferasirox | |
| MX362637B (es) | Sistema emulsionante. | |
| WO2014162320A3 (en) | Novel analogues of epicatechin and related polyphenols | |
| WO2014044461A3 (de) | Stabilisierung von kapselsystemen in wasch- und reinigungsmitteln | |
| EP3180118A4 (en) | Systems and methods for synthesizing chemical products, including active pharmaceutical ingredients | |
| HK1203815A1 (en) | Pharmaceutical compositions and methods for their preparation | |
| EP2583969A4 (en) | NEW RHODANINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AIDS WITH THE RHODANIN DERIVATIVES AS ACTIVE AGENTS | |
| IL271852A (en) | Solid powder supplements containing quercetin, a process for their preparation and their formulations | |
| WO2011045760A3 (en) | Micronized olmesartan medoxomil compositions | |
| TN2017000109A1 (en) | Stabilized adrenomedullin derivatives and use thereof | |
| WO2015095659A3 (en) | Indirubin solid dispersion composition | |
| HK1250911A1 (zh) | 微凝胶颗粒 | |
| EP4582145A3 (en) | Solid state forms of ixazomib citrate | |
| EP3810662A4 (en) | AQUEOUS DISPERSIONS CONTAINING POLYESTER PARTICLES, PHOTOPOLYMERIZABLE COMPOSITIONS, ARTICLES AND PROCESSES | |
| HK1245155A1 (zh) | 制备去氧肾上腺素树脂酸盐颗粒的方法；去氧肾上腺素树脂酸盐颗粒；以及去氧肾上腺素树脂酸盐颗粒在药物制剂中的用途 | |
| WO2016069542A3 (en) | Lactone compounds and methods of making and using same | |
| WO2010068717A3 (en) | Pyrazolinone scavengers of free radicals | |
| WO2014128728A3 (en) | Solid forms of cabazitaxel and processes for preparation thereof | |
| WO2019087069A3 (en) | Pimavanserin tartrate impurities, processes for their preparation, and their use as reference standards | |
| WO2012007758A3 (en) | Pharmaceutical formulations | |
| EP3608665A4 (en) | PROCESS FOR PRODUCING A PURIFIED PRODUCT OF PROTEIN MODIFIED PHOSPHORUS INTEGRATED PARTICLE, METHOD FOR PRODUCING A FLUORESCENT dye liquor PURIFIED PRODUCT OF PROTEIN MODIFIED PHOSPHOR PARTICLES AND INTEGRATED FILTER FOR CLEANING OF A FLUORESCENT PROTEIN AND MODIFIED dye liquor PHOSPHORUS INTEGRATED PARTICLE | |
| WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
| WO2014013511A3 (en) | Rufinamide solid dispersion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |